Molecular and Cellular Pharmacology, Vol 6, No 3 (2014)

FDA Approves Opdivo for Advanced Melanoma

Abstract

The U.S. Food and Drug Administration today granted accelerated approval to Opdivo (nivolumab), a new treatment for patients with unresectable (cannot be removed by surgery) or metastatic (advanced) melanoma who no longer respond to other drugs..….(click PDF to read more)

Full Text: PDF